Also known as Starlix
Nateglinide (INN, trade name Starlix) is a drug for the treatment of type 2 diabetes. Nateglinide was developed by Ajinomoto, a Japanese company and sold by the Swiss pharmaceutical company Novartis.Source: Wikipedia
Estimated Total Cost: $104.3 for an average of 28 days supply
Patients are most commonly prescribed nateglinide to treat diabetes, chronic kidney disease, kidney failure, and rabies.